OncoLens
Founded 2017 · 34 employees on LinkedIn · 6 known investors
Find your way into OncoLens
167 people in our graph share verified history with the OncoLens team — schools, employers, funds. One of them is your warm intro.
Michel Abadiunlockedknows Anju Mathew · together at Northwestern University - Kellogg School of Management (overlapped)
×7knows the team · via Northwestern University - Kellogg School of Management
×4knows the team · via Indian Institute of Technology, Roorkee
OncoLens provides a platform that connects cancer care teams and enables multidisciplinary cancer management, helping cancer centers coordinate care, manage tumor boards, and access clinical trials and biomarker testing.
Founders & leadership
OncoLens was founded in 2017 by Anju Mathew.
AM
Anju MathewinCo-Founder and CEOAnju Mathew co-founded and leads OncoLens, a platform for multidisciplinary cancer care coordination and tumor board management. Previously, she served as head of technology and innovation at McKesson's Medical Surgical business unit and founded LumaMed, a medical device company in cancer imaging, with earlier roles at IBM, Thomson-Reuters, A.T. Kearney, and i2 Technologies.
LS
Lijo SimpsoninChief Medical Officer
Investors · 6
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BOct 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does OncoLens do?
- OncoLens provides a platform that connects cancer care teams and enables multidisciplinary cancer management, helping cancer centers coordinate care, manage tumor boards, and access clinical trials and biomarker testing.
- Who founded OncoLens?
- OncoLens was founded by Anju Mathew in 2017.
- Who are OncoLens's investors?
- OncoLens's investors include Atlanta Technology Angels, BIP Ventures, Cross-Border Impact Ventures, Martin Ventures, SeedToB, BIP Capital.